Potential use of muramyl peptides in cancer therapy.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use*; D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D001424:Bacterial Infections / Q000276:immunology; D002460:Cell Line; D006063:Chorionic Gonadotropin / Q000276:immunology; D007987:Gonadotropin-Releasing Hormone / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology; D006801:Humans; D007109:Immunity; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D051381:Rats; D013945:Thymoma / Q000276:immunology
D000906:Antibodies; D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D000119:Acetylmuramyl-Alanyl-Isoglutamine